Erasca, Inc. (ERAS) vs Immunovant, Inc. (IMVT)
- Erasca, Inc. ERAS 13.39 −9.95%
- Immunovant, Inc. IMVT 26.73 −2.84%
Erasca, Inc. and Immunovant, Inc. are both Biotechnology companies. Erasca, Inc. and Immunovant, Inc. are of similar size ($5.7B and $5.2B). Across the 9 metrics below, Erasca, Inc. leads on 6 and Immunovant, Inc. on 3.
Valuation
Profitability
| Metric | ERAS | IMVT | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (78.25%) | (80.10%) | (56.36%) |
| Return on assets | (65.25%) | (71.10%) | (48.04%) |
| Return on invested capital | (203.13%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack